Asia Pacific Cancer Immunotherapy Market Analysis (2017-2023)

  • ID: 4456900
  • Report
  • Region: Asia, Asia Pacific
  • 84 pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
1 of 4

FEATURED COMPANIES

  • Amgen Inc.
  • Astrazeneca Plc.
  • Bayer AG
  • Bristol-Myers Squibb
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • MORE
The Asia Pacific Cancer Immunotherapy Market would witness market growth of 10.9% CAGR during the forecast period (2017 - 2023). Cancer immunotherapy is the type of cancer treatment helping the immune system fight cancer. There are various kinds of cancer immunotherapies used and they are monoclonal antibody, therapeutic cancer vaccines, checkpoint inhibitors, cytokines, and others. Growing patient population that is suffering from different types of cancer such as lung cancer, breast cancer, ovarian cancer, and other cancers are the factors that drive the global cancer immunotherapy market. Additionally, growing geriatric population and governmental contribution to healthcare expenditure are some other factors that add to the market growth.

Asia-Pacific is among the major market with tremendous market potential due to rising incidence of cancer, growth in per capita income in many countries such as India and China, government initiatives to improve healthcare sector, and focus of leading market players on expanding their geographic presence in emerging Asia-Pacific countries. Major companies involved in the cancer immunotherapy market are Amgen Inc., Advaxis Inc., Merck & Co., Inc., Eli Lilly and Company, and others..

Based on Technology, the market report segments the market into Monoclonal Antibodies, Cytokines & Immunomodulators, and Other Technology. End user is segmented into Polymeric Coatings and Organic Coatings. The Application covered under the report includes Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head & Neck Cancer, and Other Cancer. The report also covers geographical segmentation of Cancer Immunotherapy market. The report also covers country wise segmentation of Cancer Immunotherapy market. The countries included in the report are China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the Cancer Immunotherapy Market. Key companies profiled in the report include Novartis Ag, Astrazeneca Plc., Amgen Inc., Immunomedics, Inc., Bayer Ag, Pfizer Inc., Bristol-Myers Squibb, Merck Sharp & Dohme Corp., Eli Lilly And Company, and F. Hoffmann-La Roche Ltd.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Amgen Inc.
  • Astrazeneca Plc.
  • Bayer AG
  • Bristol-Myers Squibb
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • MORE
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Cancer Immunotherapy Market, by Technology
1.4.2 Asia Pacific Cancer Immunotherapy Market, by Application
1.4.3 Asia Pacific Cancer Immunotherapy Market, by End User
1.4.4 Asia Pacific Cancer Immunotherapy Market, by country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.2 Drivers, Restraints and Opportunities
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Asia Pacific Cancer Immunotherapy Market
3.1 Asia Pacific Cancer Immunotherapy Market by Technology
3.1.1 Asia Pacific Monoclonal Antibodies Cancer Immunotherapy Market by Country
3.1.2 Asia Pacific Cytokines & Immunomodulators Cancer Immunotherapy Market by Country
3.1.3 Asia Pacific Other Technology Cancer Immunotherapy Market by Country

Chapter 4. Asia Pacific Cancer Immunotherapy Market by End User
4.1 Introduction
4.1.1 Asia Pacific Hospitals Cancer Immunotherapy Market by Country
4.1.2 Asia Pacific Clinics & Others Cancer Immunotherapy Market by Country

Chapter 5. Asia Pacific Cancer Immunotherapy Market by Application
5.1 Introduction
5.1.1 Asia Pacific Cancer Immunotherapy in Lung Cancer Market by Country
5.1.2 Asia Pacific Cancer Immunotherapy in Breast Cancer Market by Country
5.1.3 Asia Pacific Cancer Immunotherapy in Colorectal Cancer Market by Country
5.1.4 Asia Pacific Cancer Immunotherapy in Melanoma Market by Country
5.1.5 Asia Pacific Cancer Immunotherapy in Prostate Cancer Market by Country
5.1.6 Asia Pacific Cancer Immunotherapy in Head & Neck Cancer Market by Country
5.1.7 Asia Pacific Cancer Immunotherapy in Other Application Market by Country

Chapter 6. Asia Pacific Cancer Immunotherapy Market by Country
6.1 Introduction
6.2 China Cancer Immunotherapy Market
6.2.1 China Cancer Immunotherapy Market by Technology
6.2.2 China Cancer Immunotherapy Market by End User
6.2.3 China Cancer Immunotherapy Market by Application
6.3 Japan Cancer Immunotherapy Market
6.3.1 Japan Cancer Immunotherapy Market by Technology
6.3.2 Japan Cancer Immunotherapy Market by End User
6.3.3 Japan Cancer Immunotherapy Market by Application
6.4 India Cancer Immunotherapy Market
6.4.1 India Cancer Immunotherapy Market by Technology
6.4.2 India Cancer Immunotherapy Market by End User
6.4.3 India Cancer Immunotherapy Market by Application
6.5 South Korea Cancer Immunotherapy Market
6.5.1 South Korea Cancer Immunotherapy Market by Technology
6.5.2 South Korea Cancer Immunotherapy Market by End User
6.5.3 South Korea Cancer Immunotherapy Market by Application
6.6 Singapore Cancer Immunotherapy Market
6.6.1 Singapore Cancer Immunotherapy Market by Technology
6.6.2 Singapore Cancer Immunotherapy Market by End User
6.6.3 Singapore Cancer Immunotherapy Market by Application
6.7 Malaysia Cancer Immunotherapy Market
6.7.1 Malaysia Cancer Immunotherapy Market by Technology
6.7.2 Malaysia Cancer Immunotherapy Market by End User
6.7.3 Malaysia Cancer Immunotherapy Market by Application
6.8 Rest of Asia Pacific Cancer Immunotherapy Market
6.8.1 Rest of Asia Pacific Cancer Immunotherapy Market by Technology
6.8.2 Rest of Asia Pacific Cancer Immunotherapy Market by End User
6.8.3 Rest of Asia Pacific Cancer Immunotherapy Market by Application

Chapter 7. Company Profiles
7.1 Novartis AG
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.2 Astrazeneca Plc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.3 Amgen Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.4 Immunomedics, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Research & Development Expense
7.5 Bayer AG
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.6 Pfizer Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.7 Bristol-Myers Squibb
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expense
7.8 Merck Sharp & Dohme Corp.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.9 Eli Lilly and Company
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expense
7.1 F. Hoffmann-La Roche Ltd
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Novartis AG
  • Astrazeneca Plc.
  • Amgen Inc.
  • Immunomedics, Inc.
  • Bayer AG
  • Pfizer Inc.
  • Bristol-Myers Squibb
  • Merck Sharp & Dohme Corp.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll